• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

雷诺现象与系统性硬化症。

Raynaud's phenomenon and systemic sclerosis.

作者信息

Generini S, Kahaleh B, Matucci-Cerinic M, Pignone A, Lombardi A, Ohtsuka T

机构信息

Istituto di Clinica Medica IV, Università degli Studi di Firenze.

出版信息

Ann Ital Med Int. 1996 Apr-Jun;11(2):125-31.

PMID:8974438
Abstract

In systemic sclerosis, the exaggerated generalized vasospastic tendency is clinically represented by Raynaud's phenomenon as shown by an early digital arterial closure after cold stimulation, and by an inadequate vasodilatory response to heat. The phenomenon is not restricted to the extremities, and can also occur in internal organs. Repeated attacks of Raynaud's phenomenon may contribute to vascular disease in systemic sclerosis by a mechanism of reperfusion injury of the endothelium, and may contribute to tissue fibrosis. Although the aetiology and pathogenesis of Raynaud's phenomenon remain unknown, recent advances in the understanding of mechanisms of vascular tone control provide us with an opportunity to reconsider the pathogenetic process of Raynaud's phenomenon. It is now clear that neuropeptides, the vascular endothelium, and platelets are the three major contributors to the control of vascular tone. Our hypothesis suggests the presence of a sensory nervous system failure, leading to an unopposed endothelial and platelet control of vascular tone. Endothelial injury and platelet activation in systemic sclerosis lead to a shift in vascular function to a pro-vasospastic function not balanced by a vasodilatory sensory input; thus, enhanced vasospasm is generated. The investigation of the role of local vascular mediators in vasospasm may lead to a better understanding of vascular tone control and of Raynaud's phenomenon pathophysiology in systemic sclerosis.

摘要

在系统性硬化症中,过度的全身性血管痉挛倾向在临床上表现为雷诺现象,如冷刺激后早期手指动脉闭塞,以及对热的血管舒张反应不足。该现象不仅限于四肢,也可发生在内脏器官。雷诺现象的反复发作可能通过内皮细胞再灌注损伤机制导致系统性硬化症中的血管疾病,并可能导致组织纤维化。尽管雷诺现象的病因和发病机制尚不清楚,但对血管张力控制机制的最新认识进展为我们重新审视雷诺现象的发病过程提供了机会。现在很清楚,神经肽、血管内皮和血小板是控制血管张力的三大主要因素。我们的假设表明存在感觉神经系统功能障碍,导致血管张力不受内皮和血小板控制的影响。系统性硬化症中的内皮损伤和血小板活化导致血管功能向血管痉挛功能转变,而血管舒张感觉输入无法平衡这种转变;因此,产生了增强的血管痉挛。研究局部血管介质在血管痉挛中的作用可能有助于更好地理解血管张力控制以及系统性硬化症中雷诺现象的病理生理学。

相似文献

1
Raynaud's phenomenon and systemic sclerosis.雷诺现象与系统性硬化症。
Ann Ital Med Int. 1996 Apr-Jun;11(2):125-31.
2
[Vascular manifestations in systemic sclerosis (scleroderma)].[系统性硬化症(硬皮病)中的血管表现]
Minerva Med. 1998 May;89(5):153-61.
3
Pathogenesis of Raynaud's phenomenon.雷诺现象的发病机制。
Rheumatology (Oxford). 2005 May;44(5):587-96. doi: 10.1093/rheumatology/keh552. Epub 2005 Mar 1.
4
[Raynaud's phenomena: diagnostic and treatment study].[雷诺现象:诊断与治疗研究]
Rev Prat. 1998 Oct 1;48(15):1659-64.
5
Effect of clonazepam on Raynaud's phenomenon and fingertip ulcers in scleroderma.氯硝西泮对硬皮病中雷诺现象和指尖溃疡的影响。
Ann Pharmacother. 2007 Sep;41(9):1544-7. doi: 10.1345/aph.1K212. Epub 2007 Jul 31.
6
[Botulinum toxin type A contribution in the treatment of Raynaud's phenomenon due to systemic sclerosis].[A型肉毒杆菌毒素在治疗系统性硬化症所致雷诺现象中的作用]
Ann Chir Plast Esthet. 2013 Dec;58(6):658-62. doi: 10.1016/j.anplas.2011.11.001. Epub 2011 Dec 26.
7
Effect of ketanserin on Raynaud's phenomenon in progressive systemic sclerosis: a double-blind trial.酮色林对进行性系统性硬化症中雷诺现象的影响:一项双盲试验。
Drugs Exp Clin Res. 1985;11(9):659-63.
8
Serotonin and Raynaud's phenomenon.血清素与雷诺现象。
J Cardiovasc Pharmacol. 1985;7 Suppl 7:S95-8.
9
[Esophageal motility in Raynaud's disease, systemic scleroderma and presclerodermal Raynaud's syndrome].[雷诺病、系统性硬化症和硬皮病前期雷诺综合征中的食管动力]
Gastroenterol Clin Biol. 1985 Feb;9(2):130-5.
10
Pathophysiology and clinical consequences of Raynaud's phenomenon related to systemic sclerosis.与系统性硬化症相关的雷诺现象的病理生理学及临床后果
Rheumatology (Oxford). 2006 Oct;45 Suppl 3:iii33-5. doi: 10.1093/rheumatology/kel280.

引用本文的文献

1
Skin autofluorescence, as marker of accumulation of advanced glycation endproducts and of cumulative metabolic stress, is not increased in patients with systemic sclerosis.作为晚期糖基化终末产物积累和累积代谢应激标志物的皮肤自发荧光,在系统性硬化症患者中并未增加。
Int J Rheumatol. 2011;2011:417813. doi: 10.1155/2011/417813. Epub 2011 Sep 29.
2
No effects of bosentan on microvasculature in patients with limited cutaneous systemic sclerosis.波生坦对局限性皮肤型系统性硬化症患者微血管无影响。
Clin Rheumatol. 2009 Jul;28(7):825-33. doi: 10.1007/s10067-009-1157-4. Epub 2009 Apr 7.